This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Lung Cancer Alliance Gratified That Federal Funding For Lung Cancer Research Maintained In The FY2013 Continuing Resolution

$10.5 million funding for Department of Defense Lung Cancer Research Program Included Despite Threats of Sequestration 

WASHINGTON, March  21, 2013 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) commends the US Congress on the passage of a Continuing Resolution for the remainder of FY2013 that includes $10.5 million in funding for the Department of Defense (DOD) Lung Cancer Research Program. This would bring the total funding so far for this program, which was established in 2009, to nearly $70 million.

Through the efforts of Lung Cancer Alliance, the Lung Cancer Research Program (LCRP) was established within the Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) and allocated an initial $20 million to fund early detection research targeting at-risk military.

"With the specter of sequestration hanging over so many important programs, continued funding for the lung cancer screening program and all other programs within the CDMRP is deeply gratifying," stated Lung Cancer Alliance President and CEO, Laurie Fenton Ambrose

"Securing increased federal research funding for all aspects of lung cancer has been, and will continue to be, a core priority of our organization," Fenton Ambrose added. "And we remain grateful to congressional leaders for their continued backing of this specific and important program."

Lung cancer is the leading cause of cancer death among men and women and every ethnic group and takes more lives each year than breast, prostate, colon and pancreatic cancers combined.

Without screening, the majority of lung cancers are diagnosed at such a late stage that the five year survival rate is only 15%—virtually unchanged since the 1971 declaration of "War on Cancer."

Lung Cancer Alliance (LCA), www.lungcanceralliance.org, is committed to ending injustice and saving lives through an alliance of advocacy, education, and support. LCA provides live, professional support, referral and information services for patients, their loved ones and those at risk for lung cancer; advocates for multiple millions in public health dollars for lung cancer research; and conducts national awareness campaigns.

Follow Lung Cancer Alliance on Facebook: www.facebook.com/lungcanceralliance. Follow us on Twitter: @LCAorg.

CONTACT Kay Cofrancesco202-742-1422 kay@lungcaneralliance.org

SOURCE Lung Cancer Alliance

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,088.14 -25.40 -0.15%
S&P 500 1,988.03 +4.50 0.23%
NASDAQ 4,474.3070 +18.2910 0.41%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs